Form 4: Vir Biotechnology Director Vicki L Sato Reports Acquisition of Shares and Stock Options
SEC Form 4 Filing
Director Vicki L Sato reported acquiring 8,000 shares of common stock and 16,000 stock options in Vir Biotechnology, Inc.
Summary
- On May 30, 2024, Vicki L Sato, a director of Vir Biotechnology, Inc., reported acquiring 8,000 shares of common stock at $0 and 16,000 stock options with an exercise price of $10.39.
- Following these transactions, Sato directly owns 1,323,351 shares of common stock and 16,000 stock options.
- The stock options are exercisable from May 30, 2025, and expire on May 29, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard Form 4 filing indicating a director's acquisition of shares and options, which could be seen as a positive sign, but without further context, it's difficult to gauge the overall impact.
Positives
- A director's acquisition of shares and options may signal confidence in the company's future prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely monitored by investors to gauge sentiment and potential future performance.
Stakeholder Impact
- Shareholders may view the director's acquisition of shares and options as a positive signal, potentially increasing investor confidence.
Key Dates
| Date | Description |
|---|---|
| 05/30/2024 | Date of transaction: Acquisition of common stock and stock options. |
| 05/30/2025 | Stock options become exercisable. |
| 05/29/2034 | Expiration date of the stock options. |
| 06/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.